High correlation between serum and cerebrospinal fluid olanzapine concentrations in patients with schizophrenia or schizoaffective disorder medicating with oral olanzapine as the only antipsychotic drug / Elisabeth Skogh en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 1 (Febrero) . - pp. 4-9 Título : High correlation between serum and cerebrospinal fluid olanzapine concentrations in patients with schizophrenia or schizoaffective disorder medicating with oral olanzapine as the only antipsychotic drug Tipo de documento: texto impreso Autores: Elisabeth Skogh, Autor ; Ingemar Sjödin, Autor ; Martin Josefsson, Autor Fecha de publicación: 2022 Artículo en la página: pp. 4-9 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Olanzapina, Tabaquismo, Concentración sérica, Líquido cefalorraquídeo, Farmacogenética Resumen: The primary aim of the present study was to investigate the relationship between steady state serum and cerebrospinal fluid (CSF) concentrations of olanzapine (OLA) and its metabolite 4′-N-desmethylolanzapine (DMO) in patients with schizophrenia or schizoaffective disorder treated with oral OLA as the only antipsychotic drug. Link: ./index.php?lvl=notice_display&id=29401 [artículo] High correlation between serum and cerebrospinal fluid olanzapine concentrations in patients with schizophrenia or schizoaffective disorder medicating with oral olanzapine as the only antipsychotic drug [texto impreso] / Elisabeth Skogh, Autor ; Ingemar Sjödin, Autor ; Martin Josefsson, Autor . - 2022 . - pp. 4-9. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 1 (Febrero) . - pp. 4-9 Palabras clave: Olanzapina, Tabaquismo, Concentración sérica, Líquido cefalorraquídeo, Farmacogenética Resumen: The primary aim of the present study was to investigate the relationship between steady state serum and cerebrospinal fluid (CSF) concentrations of olanzapine (OLA) and its metabolite 4′-N-desmethylolanzapine (DMO) in patients with schizophrenia or schizoaffective disorder treated with oral OLA as the only antipsychotic drug. Link: ./index.php?lvl=notice_display&id=29401

---

1 (1 - 1 / 1)